Citicoline Supplement for Alzheimer's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a citicoline supplement can improve sleep and thinking skills in people with Alzheimer's disease. Previous studies suggest citicoline might help with memory issues. This trial aims to determine if it can also address sleep problems, which affect many with Alzheimer's and their caregivers. Participants will receive either the citicoline supplement or a placebo (a substance with no active ingredients). Ideal candidates for this trial are those diagnosed with Alzheimer's disease, living in the continental U.S., and experiencing sleep disturbances.
As an unphased trial, participants can contribute to groundbreaking research that could enhance the quality of life for those with Alzheimer's.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that citicoline, a dietary supplement, is safe and well-tolerated. Studies found that people with Alzheimer's disease who took citicoline experienced no serious side effects. Citicoline has been safely used in various groups of people with Alzheimer's at the same dose as in this trial. It is also known for effectively reaching the brain. Overall, evidence suggests that citicoline is safe for people, particularly those with Alzheimer's disease.12345
Why are researchers excited about this trial?
Unlike the standard treatments for Alzheimer's disease, which often focus on managing symptoms with medications like Donepezil or Memantine, the citicoline supplement is unique because it targets the brain's cellular health. Citicoline is a naturally occurring compound that supports the brain's phospholipid synthesis, potentially enhancing neuronal repair and function. Researchers are excited about this treatment because it offers a novel mechanism of action that could not only slow cognitive decline but also improve overall brain health, which current options do not directly address.
What evidence suggests that this citicoline supplement might be an effective treatment for Alzheimer's disease?
Research shows that citicoline can help with brain health. Studies have found that citicoline improves memory and mental clarity, especially in older adults. In this trial, participants with Alzheimer's disease will receive either a citicoline supplement or a placebo. Treatments including citicoline have effectively boosted brain function. Citicoline is also safe, with studies showing it is well tolerated by Alzheimer's patients. While this study examines how citicoline might improve sleep, existing evidence supports its role in enhancing brain function.24567
Who Is on the Research Team?
Victoria Pak, PhD, MS, MTR
Principal Investigator
Emory School of Nursing, School of Public Health
Are You a Good Fit for This Trial?
This trial is for adults with Alzheimer's Disease living in the continental U.S. who can read English and have internet access. It excludes those with severe health issues like heart failure, diabetes type I, liver cirrhosis; psychiatric disorders; sleep apnea; or a history of substance abuse.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either citicoline or placebo for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Citicoline supplement
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Emory Goizueta Alzheimer's Disease Research Center (ADRC)
Collaborator
National Institute on Aging (NIA)
Collaborator
Goizueta Alzheimer's Disease Research Center (ADRC)
Collaborator